These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 27712128)

  • 1. Association between Q192R paraoxonase 1 polymorphism and serumadipocyte-fatty acid binding protein (FABP4) levels in Mexican women.
    Ochoa-Martínez ÁC; Ruíz-Vera T; Orta-García ST; Domínguez-Cortinas G; Jiménez-Avalos JA; Pérez-Maldonado IN
    Ann Hum Biol; 2017 Jun; 44(4):389-391. PubMed ID: 27712128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of Human Paraoxonase-1 Polymorphism (Q192R) on Serum Levels of Clinical Biomarkers Indicatives of Cardiovascular Diseases Risk in Mexican Women.
    Ochoa-Martínez ÁC; Orta-García ST; Varela-Silva JA; Pérez-Maldonado IN
    Biochem Genet; 2020 Oct; 58(5):801-820. PubMed ID: 32519276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence on serum asymmetric dimethylarginine (ADMA) concentrations of human paraoxonase 1 polymorphism (Q192R) and exposure to polycyclic aromatic hydrocarbons (PAHs) in Mexican women, a gene-environment interaction.
    Ochoa-Martínez ÁC; Ruíz-Vera T; Almendarez-Reyna CI; Orta-García ST; Pérez-Maldonado IN
    Chemosphere; 2017 Nov; 186():770-779. PubMed ID: 28821001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of gene-environment interaction (arsenic exposure - PON1 Q192R polymorphism) on cardiovascular disease biomarkers in Mexican population.
    Ochoa-Martínez ÁC; Araiza-Gamboa Y; Varela-Silva JA; Orta-García ST; Carrizales-Yáñez L; Pérez-Maldonado IN
    Environ Toxicol Pharmacol; 2021 Jan; 81():103519. PubMed ID: 33164855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations between paraoxonase 1 (PON1) polymorphisms and susceptibility and PON1 activity in rheumatoid arthritis patients, and comparison of PON1 activity in patients and controls: a meta-analysis.
    Bae SC; Lee YH
    Clin Rheumatol; 2019 Aug; 38(8):2141-2149. PubMed ID: 30868319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Q192R polymorphism of paraoxonase 1 gene associated with insulin resistance in Mexican children.
    Alegría-Torres JA; García-Domínguez ML; Cruz M; Aradillas-García C
    Arch Med Res; 2015 Jan; 46(1):78-83. PubMed ID: 25500007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Q192R polymorphism in the PON1 gene and familial hypercholesterolemia in a Saudi population.
    Alharbi KK; Alnbaheen MS; Alharbi FK; Hasanato RM; Khan IA
    Ann Saudi Med; 2017; 37(6):425-432. PubMed ID: 29229890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association of paraoxonase I gene polymorphisms Q192R (rs662) and L55M (rs854560) and its activity with metabolic syndrome components in fars ethnic group.
    Marjani A; Poursharifi N; Hashemi MM; Sajedi A; Tatari M
    Horm Mol Biol Clin Investig; 2023 Sep; 44(3):295-303. PubMed ID: 36793191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Q192R polymorphism in the PON1 gene and nasal polyp in a Turkish population.
    Solmaz Avcikurt A; Gencer N; Yazici H
    J Biochem Mol Toxicol; 2021 Jan; 35(1):e22628. PubMed ID: 32905659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between
    Biswas M; Kali SK; Sarker AK; Sukasem C
    Expert Opin Drug Saf; 2023; 22(9):807-817. PubMed ID: 37148265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Phenotypic Variants of Paraoxonase Q192R in Bipolar Disorder,Depression and Schizophrenia].
    Atagün Mİ; Tunç S; Alışık M; Erel Ö
    Turk Psikiyatri Derg; 2018; 29(2):79-86. PubMed ID: 30215835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between human paraoxonase-1 activity and PON1 polymorphisms in Mexican workers exposed to organophosphate pesticides.
    López-Flores I; Lacasaña M; Blanco-Muñoz J; Aguilar-Garduño C; Sanchez-Villegas P; Pérez-Méndez OA; Gamboa-Avila R
    Toxicol Lett; 2009 Jul; 188(2):84-90. PubMed ID: 19446239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paraoxonase (Pon1) Q192R polymorphism and serum Pon1 activity in diabetic patients on maintenance hemodialysis.
    Zhang B; Eto S; Fan P; Bian C; Shimoji E; Saito T; Saku K
    Clin Nephrol; 2003 Oct; 60(4):257-65. PubMed ID: 14579940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paraoxonase 1 (PON1) Q192R Gene Polymorphism and Cancer Risk: A Meta-Analysis Based on 30 Publications.
    Zhang M; Xiong H; Fang L; Lu W; Wu X; Huang ZS; Wang YQ; Cai ZM; Wu S
    Asian Pac J Cancer Prev; 2015; 16(10):4457-63. PubMed ID: 26028114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human serum paraoxonase gene polymorphisms, Q192R and L55M, are not associated with the risk of cerebral infarction in Chinese Han population.
    Huang Q; Liu YH; Yang QD; Xiao B; Ge L; Zhang N; Xia J; Zhang L; Liu ZJ
    Neurol Res; 2006 Jul; 28(5):549-54. PubMed ID: 16808888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PON1 Q192R genotype influences clopidogrel responsiveness by relative platelet inhibition instead of on-treatment platelet reactivity.
    Li X; Zhang L; Chen X; Qu F; Li J; Ma C; Yang J; Xu B; Wang H; Xu Q; Zhang Y; Li Y; Lu C; Yin T
    Thromb Res; 2013 Oct; 132(4):444-9. PubMed ID: 23993903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of paraoxonase 1 (PON1) polymorphisms on cancer risk: evidence from 25 published studies.
    Fang DH; Fan CH; Ji Q; Qi BX; Li J; Wang L
    Mol Biol Rep; 2012 Jun; 39(6):6801-9. PubMed ID: 22322559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do PON1-Q192R and PON1-L55M polymorphisms modify the effects of hypoxic training on paraoxonase and arylesterase activity?
    Yigittürk O; Turgay F; Kızıldağ S; Özsoylu D; Balcı GA
    J Sport Health Sci; 2023 Mar; 12(2):266-274. PubMed ID: 33188964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paraoxonase 1 (PON1) Q192R genotypes and their interaction with smoking strongly increase atherogenicity and the Framingham risk score.
    Souza-Nogueira A; Camargo AE; Remondi FA; Paoliello MM; Richter RJ; Furlong CE; Barbosa DS; Maes M; Moreira EG
    Arch Endocrinol Metab; 2016 Oct; 60(5):426-435. PubMed ID: 27812605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PON1 Q192R genetic variant and response to clopidogrel and prasugrel: pharmacokinetics, pharmacodynamics, and a meta-analysis of clinical outcomes.
    Mega JL; Close SL; Wiviott SD; Man M; Duvvuru S; Walker JR; Sundseth SS; Collet JP; Delaney JT; Hulot JS; Murphy SA; Paré G; Price MJ; Sibbing D; Simon T; Trenk D; Antman EM; Sabatine MS
    J Thromb Thrombolysis; 2016 Apr; 41(3):374-83. PubMed ID: 26573179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.